<?xml version="1.0" encoding="UTF-8"?>
<p>Research in workplaces will need support from OHS as well as other stakeholders to systematically collect ‘routine’ data such as ‘sickness absence’ as well as pandemic-specific data (e.g. RNA swab tests and serology). Consideration needs to be given as to whether some workforces (such as in health care) with a higher potential for exposure might contribute to ‘Phase 2’ clinical trials of vaccines against Covid-19.</p>
